Genomics is changing lives, it is reshaping economies and shifting health outcomes. British Columbia is at the leading edge in the implementation of genomic research and in practice.
The role of that research in BC took a big leap forward when six new projects in precision health care were awarded more than 60 million dollars in funding. Funding that helps establish British Columbia as a genomics-driven life sciences supercluster.
Precision health care is shifting the way we interact with our health, medical practitioners and the healthcare system. Utilizing genomics, we can diagnose potential health threats in advance and guide treatments that are specific to individuals like you and me.
Already, the BC Pharmacy Association is employing Pharmacogenomics to ensure you receive the right medication in the right dose at the right time. It doesn’t stop there, treatment for childhood diseases in indigenous populations and pharmacogenomics in childhood cancer treatment are two of the funded projects.
The investment is a validation of the extraordinary genomic research underway in BC.
We asked GenomeBC Chief Science Officer Catalina Lopez-Correa to join us for a Conversation That Matters about how genomics is reshaping our lives.